Cargando…
Diabetes mellitus im Kindes- und Jugendalter (Update 2023)
In contrast to adults, type 1 diabetes mellitus (T1D) is the most frequent form of diabetes in childhood and adolescence (> 90%). After diagnosis the management of children and adolescents with T1D should take place in highly specialized pediatric units experienced in pediatric diabetology. The l...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132915/ https://www.ncbi.nlm.nih.gov/pubmed/37101031 http://dx.doi.org/10.1007/s00508-023-02169-5 |
_version_ | 1785031489566539776 |
---|---|
author | Rami-Merhar, Birgit Fröhlich-Reiterer, Elke Hofer, Sabine E. Fritsch, Maria |
author_facet | Rami-Merhar, Birgit Fröhlich-Reiterer, Elke Hofer, Sabine E. Fritsch, Maria |
author_sort | Rami-Merhar, Birgit |
collection | PubMed |
description | In contrast to adults, type 1 diabetes mellitus (T1D) is the most frequent form of diabetes in childhood and adolescence (> 90%). After diagnosis the management of children and adolescents with T1D should take place in highly specialized pediatric units experienced in pediatric diabetology. The lifelong substitution of insulin is the cornerstone of treatment whereby modalities need to be individually adapted for patient age and the family routine. In this age group the usage of diabetes technology (glucose sensors, insulinpumps and recently hybrid-closed-loop-systems) is recommended. An optimal metabolic control right from the start of therapy is associated with an improved long-term prognosis. Diabetes education is essential in the management of patients with diabetes and their families and needs to be performed by a multidisciplinary team consisting of a pediatric diabetologists, diabetes educator, dietitian, psychologist and social worker. The Austrian working group for pediatric endocrinology and diabetes (APEDÖ) and the ISPAD (International Society for Pediatric and Adolescent Diabetes) recommend a metabolic goal of HbA1c ≤ 7.0%, ((IFCC) < 53 mmol/mol), and a “Time in range” > 70% for all pediatric age groups without the presence of severe hypoglycemia. Age-related physical, cognitive and psychosocial development, screening for associated diseases, avoidance of acute diabetes-related complications (severe hypoglycemia, diabetic ketoacidosis) and prevention of diabetes-related late complications to ensure high quality of life are the main goals of diabetes treatment in all pediatric age groups. |
format | Online Article Text |
id | pubmed-10132915 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Vienna |
record_format | MEDLINE/PubMed |
spelling | pubmed-101329152023-04-27 Diabetes mellitus im Kindes- und Jugendalter (Update 2023) Rami-Merhar, Birgit Fröhlich-Reiterer, Elke Hofer, Sabine E. Fritsch, Maria Wien Klin Wochenschr Leitlinien Für Die Praxis In contrast to adults, type 1 diabetes mellitus (T1D) is the most frequent form of diabetes in childhood and adolescence (> 90%). After diagnosis the management of children and adolescents with T1D should take place in highly specialized pediatric units experienced in pediatric diabetology. The lifelong substitution of insulin is the cornerstone of treatment whereby modalities need to be individually adapted for patient age and the family routine. In this age group the usage of diabetes technology (glucose sensors, insulinpumps and recently hybrid-closed-loop-systems) is recommended. An optimal metabolic control right from the start of therapy is associated with an improved long-term prognosis. Diabetes education is essential in the management of patients with diabetes and their families and needs to be performed by a multidisciplinary team consisting of a pediatric diabetologists, diabetes educator, dietitian, psychologist and social worker. The Austrian working group for pediatric endocrinology and diabetes (APEDÖ) and the ISPAD (International Society for Pediatric and Adolescent Diabetes) recommend a metabolic goal of HbA1c ≤ 7.0%, ((IFCC) < 53 mmol/mol), and a “Time in range” > 70% for all pediatric age groups without the presence of severe hypoglycemia. Age-related physical, cognitive and psychosocial development, screening for associated diseases, avoidance of acute diabetes-related complications (severe hypoglycemia, diabetic ketoacidosis) and prevention of diabetes-related late complications to ensure high quality of life are the main goals of diabetes treatment in all pediatric age groups. Springer Vienna 2023-04-20 2023 /pmc/articles/PMC10132915/ /pubmed/37101031 http://dx.doi.org/10.1007/s00508-023-02169-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access Dieser Artikel wird unter der Creative Commons Namensnennung 4.0 International Lizenz veröffentlicht, welche die Nutzung, Vervielfältigung, Bearbeitung, Verbreitung und Wiedergabe in jeglichem Medium und Format erlaubt, sofern Sie den/die ursprünglichen Autor(en) und die Quelle ordnungsgemäß nennen, einen Link zur Creative Commons Lizenz beifügen und angeben, ob Änderungen vorgenommen wurden. Die in diesem Artikel enthaltenen Bilder und sonstiges Drittmaterial unterliegen ebenfalls der genannten Creative Commons Lizenz, sofern sich aus der Abbildungslegende nichts anderes ergibt. Sofern das betreffende Material nicht unter der genannten Creative Commons Lizenz steht und die betreffende Handlung nicht nach gesetzlichen Vorschriften erlaubt ist, ist für die oben aufgeführten Weiterverwendungen des Materials die Einwilligung des jeweiligen Rechteinhabers einzuholen. Weitere Details zur Lizenz entnehmen Sie bitte der Lizenzinformation auf http://creativecommons.org/licenses/by/4.0/deed.de (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Leitlinien Für Die Praxis Rami-Merhar, Birgit Fröhlich-Reiterer, Elke Hofer, Sabine E. Fritsch, Maria Diabetes mellitus im Kindes- und Jugendalter (Update 2023) |
title | Diabetes mellitus im Kindes- und Jugendalter (Update 2023) |
title_full | Diabetes mellitus im Kindes- und Jugendalter (Update 2023) |
title_fullStr | Diabetes mellitus im Kindes- und Jugendalter (Update 2023) |
title_full_unstemmed | Diabetes mellitus im Kindes- und Jugendalter (Update 2023) |
title_short | Diabetes mellitus im Kindes- und Jugendalter (Update 2023) |
title_sort | diabetes mellitus im kindes- und jugendalter (update 2023) |
topic | Leitlinien Für Die Praxis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132915/ https://www.ncbi.nlm.nih.gov/pubmed/37101031 http://dx.doi.org/10.1007/s00508-023-02169-5 |
work_keys_str_mv | AT ramimerharbirgit diabetesmellitusimkindesundjugendalterupdate2023 AT frohlichreitererelke diabetesmellitusimkindesundjugendalterupdate2023 AT hofersabinee diabetesmellitusimkindesundjugendalterupdate2023 AT fritschmaria diabetesmellitusimkindesundjugendalterupdate2023 |